NCT00238251View on ClinicalTrials.gov

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

November 30, 2010

Conditions
Lung CancerMetastatic Cancer
Interventions
DRUG

gefitinib

Once daily during days 1-28

DRUG

temozolomide

Once daily on days 1-21

RADIATION

radiation therapy

Whole brain radiotherapy

Trial Locations (3)

CH-6500

Oncology Institute of Southern Switzerland, Bellinzona

CH-7000

Kantonsspital Graubuenden, Chur

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00238251 - Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases | Biotech Hunter | Biotech Hunter